BSE filing, NSE: PFOCUS. Summary written from the filing by ALFA Finder's alert engine.
Prime Focus Ltd: key numbers
- Share price
- ₹294.25
- Market cap
- ₹22,915 Cr
- Revenue (annual)
- ₹4,676 Cr
- Net profit (annual)
- ₹301.4 Cr
- P/E (TTM)
- 151.8×Sector 28.6×
- Promoter holding
- 60.55%-0.18% QoQ
- FII holding
- 2.97%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Prime Focus Ltd
All →Prime Focus Annual General Meeting
Prime Focus Limited convened an Extraordinary General Meeting for Nov 7, 2026. Agenda items include approving material related party transactions valued at Rs. 265.67 Crore.
- Value
- ₹265.7 Cr
Prime Focus Annual General Meeting
Prime Focus Limited has scheduled an Extra-Ordinary General Meeting (EOGM) for November 07, 2026, to be held via video conferencing to approve various related party transactions.
Prime Focus ED Probe / Tax Survey
Prime Focus confirmed an ongoing Income Tax Department search at its Mumbai offices on 7 Oct 2026. No findings or demands received; operations continue unaffected.
Prime Focus Merger & Restructuring
Prime Focus Limited's shareholders approved the previously announced transfer of its subsidiary, Prime Focus Technologies Inc., to DNEG S.a.r.l. at the recent AGM.
Prime Focus Capital Structure Change
Prime Focus Limited shareholders approved increasing the authorized share capital to Rs. 100 Crore at the AGM. The expansion from 85 Crore shares supports future capital raising through equity or debt.
Prime Focus Management Change
Prime Focus Limited has announced the re-designation of Mr. Namit Naresh Malhotra from Non-Executive Director to Executive Director. The change is effective from August 07, 2026.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.